Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
17(89.5%)
Phase 1
1(5.3%)
Early Phase 1
1(5.3%)
19Total
N/A(17)
Phase 1(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT02088645Phase 1Active Not Recruiting

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Role: collaborator

NCT06036407Not ApplicableCompleted

Screening for Hearing Loss After Childhood Cancer

Role: collaborator

NCT05890677Not ApplicableRecruiting

The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema

Role: collaborator

NCT07202936Recruiting

Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe

Role: collaborator

NCT04236791Not ApplicableActive Not Recruiting

The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up

Role: collaborator

NCT05406063Not ApplicableRecruiting

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases

Role: collaborator

NCT05256862Completed

Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania

Role: collaborator

NCT04859400Not ApplicableCompleted

Influence of a Home-based Nutrition and Exercise Program on Quality of Life of Palliative Cancer Outpatients

Role: collaborator

NCT03612544Not ApplicableCompleted

The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Role: collaborator

NCT03603353Not ApplicableCompleted

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Sleep Quality.

Role: collaborator

NCT04617444Not ApplicableCompleted

The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function

Role: collaborator

NCT03612375Not ApplicableCompleted

ESTxENDS Trial-Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in Urine

Role: collaborator

NCT03603340Not ApplicableCompleted

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Depression

Role: collaborator

NCT04244773Not ApplicableCompleted

ESTxENDS Trial: MN Substudy - Micronuclei in Buccal Epithelium, a Surrogate Measure of Future Cancer Risk, Induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Role: collaborator

NCT03632421Not ApplicableCompleted

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on Respiratory Symptoms

Role: collaborator

NCT03612336Not ApplicableCompleted

The ESTxENDS Trial- Substudy on the Metabolic Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Role: collaborator

NCT04254926Not ApplicableCompleted

Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients

Role: collaborator

NCT05606588Not ApplicableRecruiting

Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy

Role: collaborator

NCT03647657Early Phase 1Completed

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Role: collaborator

NCT04484064Not ApplicableRecruiting

Optimization of the Targeted Anticancer Therapies

Role: collaborator